The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

Although it is clear that microtubule associated protein tau (MAPT) is involved in Alzheimer's disease (AD) pathology, it has not been clear whether it is involved genetically. We have recently examined the MAPT locus in progressive supranuclear palsy and found that a haplotype (H1c) on the background of the well-described H1 clade is associated with PSP. Here we report that the same haplotype is associated with the risk of AD in two autopsy confirmed series of cases with ages at death >65 years.

[1]  D W Dickson,et al.  Neuropathology of Alzheimer's disease and other dementias. , 2001, Clinics in geriatric medicine.

[2]  B. Winblad,et al.  Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer’s disease , 1999, Neuroscience Letters.

[3]  A. Singleton,et al.  The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases. , 2004, Human molecular genetics.

[4]  A J Lees,et al.  Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration , 2005, Journal of Medical Genetics.

[5]  E. Green,et al.  A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain , 2002, Neuroscience Letters.

[6]  M. Gold,et al.  No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples , 1999, Neuroscience Letters.

[7]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[8]  M. Bullido,et al.  A polymorphism in the tau gene associated with risk for Alzheimer's disease , 2000, Neuroscience Letters.

[9]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[10]  S. Lovestone,et al.  The microtubule associated protein Tau gene and Alzheimer's disease – an association study and meta-analysis , 2001, Neuroscience Letters.

[11]  E. Tolosa,et al.  Novel haplotypes in 17q21 are associated with progressive supranuclear palsy , 2004, Annals of neurology.

[12]  Nicholas W Wood,et al.  The structure of the tau haplotype in controls and in progressive supranuclear palsy. , 2004, Human molecular genetics.

[13]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[14]  A. Hofman,et al.  Mutation screening of the tau gene in patients with early-onset Alzheimer's disease , 1999, Neuroscience Letters.

[15]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[16]  M N Rossor,et al.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype , 2001, Neurology.

[17]  M. Pericak-Vance,et al.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype , 2004, Neurogenetics.

[18]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Farrer,et al.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease. , 2004, American journal of human genetics.

[20]  John Hardy,et al.  Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau , 1998, Nature Neuroscience.